Ziegler JB - Search Results

1

Arts SE, Abu-Saad HH, Champion GD, Crawford MR, Fisher RJ, Juniper KH, Ziegler JB. Arts SE, et al. Among authors: ziegler jb. Pediatrics. 1994 May;93(5):797-801. Pediatrics. 1994. PMID: 8165081 Review.

2

An investigation of the placebo effect and age-related factors in the report of needle pain from venipuncture in children.

Goodenough B, Kampel L, Champion GD, Laubreaux L, Nicholas MK, Ziegler JB, McInerney M. Goodenough B, et al. Among authors: ziegler jb. Pain. 1997 Sep;72(3):383-91. doi: 10.1016/s0304-3959(97)00062-6. Pain. 1997. PMID: 9313279 Clinical Trial.

3

Pain in 4- to 6-year-old children receiving intramuscular injections: a comparison of the Faces Pain Scale with other self-report and behavioral measures.

Goodenough B, Addicoat L, Champion GD, McInerney M, Young B, Juniper K, Ziegler JB. Goodenough B, et al. Among authors: ziegler jb. Clin J Pain. 1997 Mar;13(1):60-73. doi: 10.1097/00002508-199703000-00009. Clin J Pain. 1997. PMID: 9084953 Clinical Trial.

4

Unravelling age effects and sex differences in needle pain: ratings of sensory intensity and unpleasantness of venipuncture pain by children and their parents.

Goodenough B, Thomas W, Champion GD, Perrott D, Taplin JE, von Baeyer CL, Ziegler JB. Goodenough B, et al. Among authors: ziegler jb. Pain. 1999 Mar;80(1-2):179-90. doi: 10.1016/s0304-3959(98)00201-2. Pain. 1999. PMID: 10204730 Clinical Trial.

5

The gold complexes.

Champion GD, Graham GG, Ziegler JB. Champion GD, et al. Among authors: ziegler jb. Baillieres Clin Rheumatol. 1990 Dec;4(3):491-534. doi: 10.1016/s0950-3579(05)80005-6. Baillieres Clin Rheumatol. 1990. PMID: 2093439 Review. No abstract available.

6

Medicinal chemistry of gold.

Graham GG, Ziegler JB, Champion GD. Graham GG, et al. Among authors: ziegler jb. Agents Actions Suppl. 1993;44:209-17. Agents Actions Suppl. 1993. PMID: 8103963 Review.

7

The cellular metabolism and effects of gold complexes.

Graham GG, Champion GD, Ziegler JB. Graham GG, et al. Among authors: ziegler jb. Met Based Drugs. 1994;1(5-6):395-404. doi: 10.1155/MBD.1994.395. Met Based Drugs. 1994. PMID: 18476258 Free PMC article.

8

Auranofin inhibits the activation pathways of polymorphonuclear leukocytes at multiple sites.

Rudkowski R, Ziegler JB, Graham GG, Champion GD. Rudkowski R, et al. Among authors: ziegler jb. Biochem Pharmacol. 1991 Jun 15;41(12):1921-9. doi: 10.1016/0006-2952(91)90132-o. Biochem Pharmacol. 1991. PMID: 1645553

9

The effect of aurothiomalate on the oxidative burst of polymorphonuclear leukocytes varies with the quantity of drug in myocrisin ampoules.

Rudkowski R, Graham GG, Ziegler JB, Champion GD. Rudkowski R, et al. Among authors: ziegler jb. J Rheumatol. 1991 May;18(5):666-71. J Rheumatol. 1991. PMID: 1907663

10

The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes--I. The effects of aurocyanide on the oxidative burst of polymorphonuclear leukocytes.

Rudkowski R, Graham GG, Champion GD, Ziegler JB. Rudkowski R, et al. Among authors: ziegler jb. Biochem Pharmacol. 1990 Jun 1;39(11):1687-95. doi: 10.1016/0006-2952(90)90112-x. Biochem Pharmacol. 1990. PMID: 2160817

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

146 results

Search Page